SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-015270
Filing Date
2022-03-28
Accepted
2022-03-28 06:50:57
Documents
195
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2021_biondvax.htm   iXBRL 20-F 2439257
2 EMPLOYMENT AGREEMENT DATED JANUARY 20, 2021, BETWEEN BIONDVAX PHARMACEUTICALS LT f20f2021ex4-4_biondvax.htm EX-4.4 84052
3 LICENSE AGREEMENT, DATED DECEMBER 11, 2021, BETWEEN BIONDVAX PHARMACEUTICALS LTD f20f2021ex4-16_biondvax.htm EX-4.16 45697
4 ACCOMPANYING RESEARCH COLLABORATION AGREEMENT, DATED DECEMBER 11, 2021 f20f2021ex4-17_biondvax.htm EX-4.17 35020
5 RESEARCH COLLABORATION AGREEMENT, DATED MARCH 23, 2022, BETWEEN BIONDVAX PHARMAC f20f2021ex4-18_biondvax.htm EX-4.18 329555
6 FORM OF LICENSE AGREEMENT BETWEEN BIONDVAX PHARMACEUTICALS LTD., MAX-PLANCK-GESE f20f2021ex4-19_biondvax.htm EX-4.19 483781
7 CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A M f20f2021ex10_biondvax.htm EX-10 1838
8 CERTIFICATION f20f2021ex12-1_biondvax.htm EX-12.1 10161
9 CERTIFICATION f20f2021ex12-2_biondvax.htm EX-12.2 10270
10 CERTIFICATION f20f2021ex13-1_biondvax.htm EX-13.1 3684
11 CERTIFICATION f20f2021ex13-2_biondvax.htm EX-13.2 3541
17 GRAPHIC ex10-16_001.jpg GRAPHIC 65650
18 GRAPHIC ex10-16_002.jpg GRAPHIC 358133
19 GRAPHIC ex10-16_003.jpg GRAPHIC 297199
20 GRAPHIC ex10-16_004.jpg GRAPHIC 304720
21 GRAPHIC ex10-16_005.jpg GRAPHIC 352470
22 GRAPHIC ex10-16_006.jpg GRAPHIC 274921
23 GRAPHIC ex10-16_007.jpg GRAPHIC 344527
24 GRAPHIC ex10-16_008.jpg GRAPHIC 273359
25 GRAPHIC ex10-16_009.jpg GRAPHIC 327862
26 GRAPHIC ex10-16_010.jpg GRAPHIC 372918
27 GRAPHIC ex10-16_011.jpg GRAPHIC 356238
28 GRAPHIC ex10-16_012.jpg GRAPHIC 301319
29 GRAPHIC ex10-16_013.jpg GRAPHIC 342982
30 GRAPHIC ex10-16_014.jpg GRAPHIC 271628
31 GRAPHIC ex10-16_015.jpg GRAPHIC 356283
32 GRAPHIC ex10-16_016.jpg GRAPHIC 334967
33 GRAPHIC ex10-16_017.jpg GRAPHIC 330849
34 GRAPHIC ex10-16_018.jpg GRAPHIC 363334
35 GRAPHIC ex10-16_019.jpg GRAPHIC 343836
36 GRAPHIC ex10-16_020.jpg GRAPHIC 327535
37 GRAPHIC ex10-16_021.jpg GRAPHIC 308054
38 GRAPHIC ex10-16_022.jpg GRAPHIC 302160
39 GRAPHIC ex10-16_023.jpg GRAPHIC 363464
40 GRAPHIC ex10-16_024.jpg GRAPHIC 310164
41 GRAPHIC ex10-16_025.jpg GRAPHIC 171416
42 GRAPHIC ex10-16_026.jpg GRAPHIC 237254
43 GRAPHIC ex10-16_027.jpg GRAPHIC 185317
44 GRAPHIC ex10-16_028.jpg GRAPHIC 119017
45 GRAPHIC ex10-16_029.jpg GRAPHIC 288244
46 GRAPHIC ex10-16_030.jpg GRAPHIC 207522
47 GRAPHIC ex10-16_031.jpg GRAPHIC 277913
48 GRAPHIC ex10-16_032.jpg GRAPHIC 295751
49 GRAPHIC ex10-16_033.jpg GRAPHIC 310982
50 GRAPHIC ex10-16_034.jpg GRAPHIC 334972
51 GRAPHIC ex10-16_035.jpg GRAPHIC 374541
52 GRAPHIC ex10-16_036.jpg GRAPHIC 310910
53 GRAPHIC ex10-16_037.jpg GRAPHIC 337707
54 GRAPHIC ex10-16_038.jpg GRAPHIC 344264
55 GRAPHIC ex10-16_039.jpg GRAPHIC 324064
56 GRAPHIC ex10-16_040.jpg GRAPHIC 281633
57 GRAPHIC ex10-16_041.jpg GRAPHIC 216305
58 GRAPHIC ex10-16_042.jpg GRAPHIC 340897
59 GRAPHIC ex10-16_043.jpg GRAPHIC 341206
60 GRAPHIC ex10-16_044.jpg GRAPHIC 297913
61 GRAPHIC ex10-16_045.jpg GRAPHIC 182925
62 GRAPHIC ex10-16_046.jpg GRAPHIC 353455
63 GRAPHIC ex10-16_047.jpg GRAPHIC 307805
64 GRAPHIC ex10-16_048.jpg GRAPHIC 260184
65 GRAPHIC ex10-16_049.jpg GRAPHIC 80959
66 GRAPHIC ex10-16_050.jpg GRAPHIC 24312
67 GRAPHIC ex10-16_051.jpg GRAPHIC 23056
68 GRAPHIC ex10-16_052.jpg GRAPHIC 44300
69 GRAPHIC ex10-16_053.jpg GRAPHIC 43817
70 GRAPHIC ex10-16_054.jpg GRAPHIC 26968
71 GRAPHIC ex10-16_055.jpg GRAPHIC 25669
72 GRAPHIC ex10-16_056.jpg GRAPHIC 28530
73 GRAPHIC ex10-16_057.jpg GRAPHIC 27393
74 GRAPHIC ex10-16_058.jpg GRAPHIC 26629
75 GRAPHIC ex10-16_059.jpg GRAPHIC 24741
76 GRAPHIC ex10-16_060.jpg GRAPHIC 52663
77 GRAPHIC ex10-16_061.jpg GRAPHIC 47500
78 GRAPHIC ex10-16_062.jpg GRAPHIC 67244
79 GRAPHIC ex10-16_063.jpg GRAPHIC 65202
80 GRAPHIC ex10-17_001.jpg GRAPHIC 113442
81 GRAPHIC ex10-17_002.jpg GRAPHIC 337629
82 GRAPHIC ex10-17_003.jpg GRAPHIC 278213
83 GRAPHIC ex10-17_004.jpg GRAPHIC 311700
84 GRAPHIC ex10-17_005.jpg GRAPHIC 270858
85 GRAPHIC ex10-17_006.jpg GRAPHIC 298870
86 GRAPHIC ex10-17_007.jpg GRAPHIC 297475
87 GRAPHIC ex10-17_008.jpg GRAPHIC 272859
88 GRAPHIC ex10-17_009.jpg GRAPHIC 342199
89 GRAPHIC ex10-17_010.jpg GRAPHIC 307071
90 GRAPHIC ex10-17_011.jpg GRAPHIC 371816
91 GRAPHIC ex10-17_012.jpg GRAPHIC 341169
92 GRAPHIC ex10-17_013.jpg GRAPHIC 222691
93 GRAPHIC ex10-17_014.jpg GRAPHIC 316732
94 GRAPHIC ex10-17_015.jpg GRAPHIC 382700
95 GRAPHIC ex10-17_016.jpg GRAPHIC 392808
96 GRAPHIC ex10-17_017.jpg GRAPHIC 409129
97 GRAPHIC ex10-17_018.jpg GRAPHIC 144378
98 GRAPHIC ex10-17_019.jpg GRAPHIC 215643
99 GRAPHIC ex10-17_020.jpg GRAPHIC 404794
100 GRAPHIC ex10-17_021.jpg GRAPHIC 296860
101 GRAPHIC ex10-17_022.jpg GRAPHIC 315326
102 GRAPHIC ex10-17_023.jpg GRAPHIC 284078
103 GRAPHIC ex10-17_024.jpg GRAPHIC 243153
104 GRAPHIC ex10-17_025.jpg GRAPHIC 56781
105 GRAPHIC ex10-17_026.jpg GRAPHIC 115955
106 GRAPHIC ex10-17_027.jpg GRAPHIC 31290
107 GRAPHIC ex10-17_028.jpg GRAPHIC 54310
108 GRAPHIC ex10-17_029.jpg GRAPHIC 250293
109 GRAPHIC ex10-17_030.jpg GRAPHIC 44833
110 GRAPHIC ex10-17_031.jpg GRAPHIC 38770
111 GRAPHIC ex10-17_032.jpg GRAPHIC 39180
112 GRAPHIC ex10-17_033.jpg GRAPHIC 26944
113 GRAPHIC ex10-17_034.jpg GRAPHIC 198614
114 GRAPHIC ex10-17_035.jpg GRAPHIC 39735
115 GRAPHIC ex10-17_036.jpg GRAPHIC 40108
116 GRAPHIC ex10-17_037.jpg GRAPHIC 39778
117 GRAPHIC ex10-17_038.jpg GRAPHIC 40112
118 GRAPHIC fin_001.jpg GRAPHIC 25395
  Complete submission text file 0001213900-22-015270.txt   42482853

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE bvxv-20211231.xsd EX-101.SCH 118565
13 XBRL CALCULATION FILE bvxv-20211231_cal.xml EX-101.CAL 30113
14 XBRL DEFINITION FILE bvxv-20211231_def.xml EX-101.DEF 302449
15 XBRL LABEL FILE bvxv-20211231_lab.xml EX-101.LAB 644363
16 XBRL PRESENTATION FILE bvxv-20211231_pre.xml EX-101.PRE 314962
189 EXTRACTED XBRL INSTANCE DOCUMENT f20f2021_biondvax_htm.xml XML 1746726
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37353 | Film No.: 22773136
SIC: 2836 Biological Products, (No Diagnostic Substances)